These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28534796)

  • 1. Predicting Progression From Mild Cognitive Impairment to Alzheimer's Disease Using Autoregressive Modelling of Longitudinal and Multimodal Biomarkers.
    Minhas S; Khanum A; Riaz F; Khan SA; Alvi A
    IEEE J Biomed Health Inform; 2018 May; 22(3):818-825. PubMed ID: 28534796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nonparametric Approach for Mild Cognitive Impairment to AD Conversion Prediction: Results on Longitudinal Data.
    Minhas S; Khanum A; Riaz F; Alvi A; Khan SA
    IEEE J Biomed Health Inform; 2017 Sep; 21(5):1403-1410. PubMed ID: 28113683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal manifold-regularized transfer learning for MCI conversion prediction.
    Cheng B; Liu M; Suk HI; Shen D; Zhang D;
    Brain Imaging Behav; 2015 Dec; 9(4):913-26. PubMed ID: 25702248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.
    Cui Y; Liu B; Luo S; Zhen X; Fan M; Liu T; Zhu W; Park M; Jiang T; Jin JS;
    PLoS One; 2011; 6(7):e21896. PubMed ID: 21814561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features.
    Minhas S; Khanum A; Alvi A; Riaz F; Khan SA; Alsolami F; A Khan M
    Comput Intell Neurosci; 2021; 2021():6628036. PubMed ID: 34608385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    Dukart J; Sambataro F; Bertolino A
    J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical markers.
    Platero C; Tobar MC;
    Brain Imaging Behav; 2021 Aug; 15(4):1728-1738. PubMed ID: 33169305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
    Grassi M; Perna G; Caldirola D; Schruers K; Duara R; Loewenstein DA
    J Alzheimers Dis; 2018; 61(4):1555-1573. PubMed ID: 29355115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment.
    Mubeen AM; Asaei A; Bachman AH; Sidtis JJ; Ardekani BA;
    J Neuroradiol; 2017 Oct; 44(6):381-387. PubMed ID: 28676345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.